Skip to main content
Springer logoLink to Springer
. 2021 Jun 23;100(8):2141–2142. doi: 10.1007/s00277-021-04564-2

Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Esther Schuler 1,, Eva-Maria Wagner-Drouet 2, Salem Ajib 3, Gesine Bug 3, Martina Crysandt 4, Sabine Dressler 5, Andreas Hausmann 6, Daniela Heidenreich 7, Klaus Hirschbühl 8, Matthias Hoepting 9, Edgar Jost 4, Jennifer Kaivers 1, Stefan Klein 7, Michael Koldehoff 10, Lambros Kordelas 10, Oliver Kriege 2, Lutz P Müller 11, Christina Rautenberg 1, Judith Schaffrath 11, Christoph Schmid 8, Daniel Wolff 9, Rainer Haas 1, Martin Bornhäuser 12, Thomas Schroeder 1, Guido Kobbe 1; On behalf of the German Cooperative Transplant Study Group
PMCID: PMC8587257  PMID: 34160650

Correction to: Annals of Hematology

10.1007/s00277-020-04321-x

The article “Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group”, written by Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt, Sabine Dressler, Andreas Hausmann, Daniela Heidenreich, Klaus Hirschbühl, Matthias Hoepting, Edgar Jost, Jennifer Kaivers, Stefan Klein, Michael Koldehoff, Lambros Kordelas, Oliver Kriege, Lutz P. Müller, Christina Rautenberg, Judith Schaffrath, Christoph Schmid, Daniel Wolff, Rainer Haas, Martin Bornhäuser, Thomas Schroeder, Guido Kobbe and On behalf of the German Cooperative Transplant Study Group, was originally published Online First without Open Access. After publication in volume 100, issue 4, page 959–968 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2021 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s00277-020-04321-x

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Annals of Hematology are provided here courtesy of Springer

RESOURCES